The International Federation of Pharmaceutical Manufacturers and Associations asked CRA to review the evidence on the factors increasing access and the associated value of innovation across low and middle income countries for HIV/AIDS from 2000 to 2015. In the report, Tim Wilsdon and Lilian Li present an analysis of access to medicines and the value that these medicines deliver to different countries. The report focuses on six countries that have made progress in providing access to antiretroviral drugs including Botswana, Brazil, China, India, Rwanda, and South Africa and identifies a number of success factors. To read the report, click the link below.
From ASP to MFP: The looming disruption of the medical benefit
Key recent developments in the program include: The first two years of the MDPNP only covered retail-dispensed therapies but starting in this selection...